Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

ACTG Feb 2022 10.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
0.20000.0000 (0.00%)
At close: 11:51AM EDT
Advertisement
Full screen
Previous Close0.2000
Open0.2000
Bid0.1000
Ask0.3000
Strike10.00
Expire Date2022-02-18
Day's Range0.2000 - 0.3000
Contract RangeN/A
Volume3
Open Interest120
  • Benzinga

    Acacia Research Acquires Printing Technology Business Printronix For $33M

    Acacia Research Corp (NASDAQ: ACTG) has acquired Printronix Holding Corp. for $33 million in cash. The purchase price represents a multiple of ~3.6x the Adjusted EBITDA generated by Printronix in the fiscal year ended March 31, 2021. Printronix is a manufacturer and distributor of industrial impact printers, known as line matrix printers, and related consumables and services. It provides customized industrial print solutions for supply chain and manufacturing processes in harsh printing environm

  • Business Wire

    Acacia Research Acquires Printronix, a Leading Printing Technology Business

    NEW YORK, October 11, 2021--Acacia Research Corporation (Nasdaq: ACTG) ("Acacia" or the "Company") today announced that it has acquired Printronix Holding Corp. ("Printronix"). Printronix is a leading manufacturer and distributor of industrial impact printers, which are also known as line matrix printers, and related consumables and services. The business services a diverse group of customers that operate across healthcare, food and beverage, manufacturing and logistics, and other sectors.

  • Business Wire

    Acacia’s Portfolio Holding, Oxford Nanopore, Completes IPO on the London Stock Exchange Generating Net Proceeds of $22.3 Million to Acacia

    NEW YORK, October 05, 2021--Acacia Research Corporation (Nasdaq: ACTG) ("Acacia") today announced that Oxford Nanopore Technologies Limited ("Oxford Nanopore"), the company behind a new generation of nanopore-based sensing technology, whose products enable the real-time, high-performance, scalable analysis of DNA and RNA, has successfully completed its Initial Public Offering of shares on the London Stock Exchange at 425 pence per share.

Advertisement
Advertisement